Haleon

Public consensus   -   Last updated 05/06/23

Contributors

  • 15 FY23 based on
  • 15 FY24 based on
  • 15 FY25 based on
Reporting currency: GBP
Reporting unit: Absolute
FY23
CONSENSUS
05/06/23
FY24
CONSENSUS
05/06/23
FY25
CONSENSUS
05/06/23
Revenue
North America
4,229
4,363
4,507
EMEA & LatAm
4,527
4,692
4,904
Asia Pacific
2,628
2,786
2,965
Group
11,385
11,841
12,376
Organic growth (%)
North America (%)
3.8
3.7
3.6
EMEA & LatAm (%)
7.1
4.1
4.3
Asia Pacific (%)
8.5
6.7
7.1
Revenue
11,379
11,843
12,383
Organic growth (%)
6.2
4.6
4.7
Adjusted EBIT
North America
1,103
1,144
1,192
EMEA & LatAm
1,044
1,098
1,164
Asia Pacific
539
584
631
Central and unallocated
(88)
(91)
(93)
Adjusted operating profit (AER)
2,601
2,739
2,898
Adjusted operating margin (AER) (%)
22.9
23.1
23.4
EBITDA
2,868
3,020
3,192
Net Interest
(348)
(301)
(262)
Adjusted PBT
2,252
2,438
2,636
Adjusted Tax
(527)
(566)
(611)
Tax rate (%)
(23)
(23)
(23)
Minority Interest
(65)
(68)
(73)
Adjusted Net Profit
1,661
1,804
1,952
EPS
17.98
19.53
21.18

Disclaimer

The forecasts in this analysis have been gathered for Haleon through Vuma Consensus, an external web-based tool independently managed by Vuma Financial Limited, a company separate from Haleon.

The analysis is provided purely for convenience of users of our website and for information purposes only. The publication of the forecasts does not imply that Haleon endorses, confirms or expresses a view on any forecast or on the analysis.

Consensus is calculated by taking the simple average of the constituent analyst forecasts. The forecasts in this analysis are from a number of registered investment analysts and these are, as such, information that is available publicly.

Vuma Financial Limited has had no access to Haleon’s internal budgets, forecasts or information which is not publicly available. Haleon does not comment on, nor does it verify or endorse, individual forecasts nor does it intend to do so in the future and the analysis is not based on Haleon’s own opinions, estimates or forecasts. Haleon assumes no liability whatsoever in connection with the accuracy, compilation, completeness or publication of consensus estimates.

Haleon assumes no obligation to update or revise such information and nothing in this analysis should be taken as a recommendation to buy or sell shares in Haleon, to take or not take any other action or to place any reliance on the analysis.